Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28

Transplantation

Volumn 75, Issue 3, 2003, Pages 418-420

  Dankers, Marlies K A ^a   Roelen, Dave L ^a   Van Der Meer Prins, Ellen M W ^a   De Lange, Peter ^a   Korfage, Nelleke ^a   Smits, Jacqueline M A ^b   Persijn, Guido G ^b   Welsh, Ken I ^c   Doxiadis, Ilias I N ^a   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; HLA A28 ANTIGEN; HLA ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOGENICITY; KIDNEY GRAFT; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANTIBODIES; EPITOPES; FEMALE; FETUS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HUMANS; KIDNEY TRANSPLANTATION; PREGNANCY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037442267     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000044456.51462.E2     Document Type: Article

References (10)

1. Thorogood J, van Houwelingen JC, van Rood JJ, et al. Factors contributing to the longterm kidney graft survival in Eurotransplant. Transplantation 1992; 54: 152.
2. Maruya E, Takemoto S, Terasaki PI. HLA matching: identification of permissible HLA mismatches. In: Terasaki PI, Cecka JM, eds. Clinical transplants. Los Angeles, UCLA Tissue Typing Laboratory 1993; 511.
3. Doxiadis IIN, Smits JMA, Schreuder GMTh, et al. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet 1996; 348: 850.
4. Garrett TPJ, Saper MA, Bjorkman PJ, et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989; 342: 692.
5. Duquesnoy RJ. HLA Matchmaker: a molecularly based donor selection algorithm for highly alloimmunized patients. Transplant Proc 2001; 33: 493.
6. Bouma GJ, van der Meer-Prins EMW, van Bree FPMJ, et al. Determination of cytotoxic T lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51. Hum Immunol 1992; 35: 85.
7. Hutchinson IV. Cellular mechanisms of allograft rejection. Curr Opin Immunol 1991; 3: 722.
8. Roelen DL, Stobbe I, Young NT, et al. Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data. Hum Immunol 2001; 62: 661.
9. Zantvoort FA, D'amaro J, Persijn GG, et al. The impact of HLA-A matching on long-term survival of renal allografts. Transplantation 1995; 61: 841.
10. Duquesnoy RJ. HLA Matchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002; 63: 339.